Eye cancer study dispels the theory of nerve activity

Article

Researchers have identified a cell that causes eye cancer, suggesting for the first time that deliberate genetic manipulations may encourage the brain to heal itself.

Researchers have identified a cell that causes eye cancer, suggesting for the first time that deliberate genetic manipulations may encourage the brain to heal itself. The study, published in Cell, has dispelled a long-standing theory about nerve growth and development.

Michael Dyer and colleagues at St Jude Children's Research Hospital, US, found that reducing the activity of the Rb genes in mice retina enables fully differentiated horizontal neurons to multiply while retaining the features of normal horizontal neurons. This demonstrates that retinoblastoma can arise from fully matured horizontal interneurons in the retina and thereby disproves the idea that fully developed nerves cannot multiply like young cells.

Based on these findings, the researchers believe that it may be possible for scientists to induce fully developed neurons to help the brain to heal itself by controlling gene activity in the neurons. This will encourage them to multiply and replace the neurons that were lost as a result of neurodegenerative diseases such as Alzheimer's.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.